Behbahani Ali is a director of Black Diamond Therapeutics Inc.
Person profile
Roles
Black Diamond Therapeutics
Director
Monte Rosa Therapeutics
Director
Minerva Surgical
Director
CRISPR Therapeutics
Director
Address
Chevy Chase, Maryland
Employees
SEC CIK
Calendar
26 Jun 22
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 17 Jun 22 | BDTX Black Diamond Therapeutics | Common Stock | Grant | Acquire A | No | No | 2.03 | 5,850 | 11.88K | 15,555 |
| 15 Jun 22 | GLUE Monte Rosa Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 7.66 | 15,000 | 114.9K | 15,000 |
| 10 Jun 22 | BDTX Black Diamond Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.14 | 15,000 | 32.1K | 15,000 |
| 10 Jun 22 | UTRS Minerva Surgical | Common Stock | Grant | Acquire A | No | No | 2.41 | 49,792 | 120K | 58,279 |
| 9 Jun 22 | CRSP CRISPR Therapeutics | Stock Option Common Shares | Grant | Acquire A | No | No | 71.7 | 12,000 | 860.4K | 12,000 |
Financial reports
No filings
Current reports
No filings
Registration and prospectus
No filings
Proxies
No filings
Other
No filings
Ownership
4
Black Diamond Therapeutics / Ali Behbahani ownership change
17 Jun 22
4
Monte Rosa Therapeutics / Ali Behbahani ownership change
16 Jun 22
4
MINERVA SURGICAL / Ali Behbahani ownership change
14 Jun 22
4
Black Diamond Therapeutics / Ali Behbahani ownership change
13 Jun 22
4
CRISPR Therapeutics / Ali Behbahani ownership change
10 Jun 22
4
Nkarta / Ali Behbahani ownership change
10 Jun 22
4
CVRx / Ali Behbahani ownership change
9 Jun 22
4
Oyster Point Pharma / Ali Behbahani ownership change
8 Jun 22
4
GENOCEA BIOSCIENCES / Ali Behbahani ownership change
26 May 22
4
Trevi Therapeutics / Ali Behbahani ownership change
13 Apr 22